ATE275133T1 - 1,2-dihydro-2-oxochinolin-derivate - Google Patents

1,2-dihydro-2-oxochinolin-derivate

Info

Publication number
ATE275133T1
ATE275133T1 AT98957145T AT98957145T ATE275133T1 AT E275133 T1 ATE275133 T1 AT E275133T1 AT 98957145 T AT98957145 T AT 98957145T AT 98957145 T AT98957145 T AT 98957145T AT E275133 T1 ATE275133 T1 AT E275133T1
Authority
AT
Austria
Prior art keywords
group
different
same
dihydro
hydrogen atom
Prior art date
Application number
AT98957145T
Other languages
English (en)
Inventor
Atsuro Nakazato
Taketoshi Okubo
Toshihito Kumagai
Shigeyuki Chaki
Kazuyuki Tomisawa
Masashi Nagamine
Makoto Gotoh
Masanori Yoshida
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE275133T1 publication Critical patent/ATE275133T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/42Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98957145T 1997-12-03 1998-12-03 1,2-dihydro-2-oxochinolin-derivate ATE275133T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33253997 1997-12-03
PCT/JP1998/005451 WO1999028299A1 (en) 1997-12-03 1998-12-03 1,2-dihydro-2-oxoquinoline derivatives

Publications (1)

Publication Number Publication Date
ATE275133T1 true ATE275133T1 (de) 2004-09-15

Family

ID=18256057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98957145T ATE275133T1 (de) 1997-12-03 1998-12-03 1,2-dihydro-2-oxochinolin-derivate

Country Status (10)

Country Link
US (2) US6329525B1 (de)
EP (1) EP1048655B1 (de)
KR (1) KR20010032667A (de)
CN (1) CN1118456C (de)
AT (1) ATE275133T1 (de)
AU (1) AU736232B2 (de)
CA (1) CA2313055A1 (de)
DE (1) DE69826034T2 (de)
ES (1) ES2227893T3 (de)
WO (1) WO1999028299A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000256323A (ja) * 1999-01-08 2000-09-19 Japan Tobacco Inc 2−オキソキノリン化合物及びその医薬用途
WO2004103974A1 (ja) * 2003-05-23 2004-12-02 Japan Tobacco Inc. 置換2-オキソキノリン化合物およびその医薬用途
SE0302323D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
WO2005021547A2 (en) * 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
WO2008113006A1 (en) * 2007-03-14 2008-09-18 Xenon Pharmaceuticals Inc. Methods of using quinolinone compounds in treating sodium channel-mediated diseases or conditions
WO2009016841A1 (ja) * 2007-08-01 2009-02-05 Kumiai Chemical Industry Co., Ltd. オキソピラジン誘導体及び除草剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
JPS63146872A (ja) 1986-07-08 1988-06-18 Yoshitomi Pharmaceut Ind Ltd ピリミジニルピペラジン化合物
JPH02152966A (ja) 1988-12-05 1990-06-12 Otsuka Pharmaceut Co Ltd 4−ヒドロキシカルボスチリル誘導体
JP3122671B2 (ja) 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
GB9108547D0 (en) 1991-04-22 1991-06-05 Fujisawa Pharmaceutical Co Quinoline derivatives
US5206382A (en) 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
FR2717175B1 (fr) 1994-03-11 1996-06-14 Adir Nouveaux composés alkylaminoindanes, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JP3888393B2 (ja) 1995-03-10 2007-02-28 大正製薬株式会社 キノロン誘導体
EP1070054A1 (de) * 1998-04-08 2001-01-24 Takeda Chemical Industries, Ltd. Aminverbindungen, ihre herstellung und ihre verwendung als somatostatin rezeptor antagonisten oder agonisten

Also Published As

Publication number Publication date
EP1048655A1 (de) 2000-11-02
WO1999028299A1 (en) 1999-06-10
ES2227893T3 (es) 2005-04-01
EP1048655B1 (de) 2004-09-01
CA2313055A1 (en) 1999-06-10
KR20010032667A (ko) 2001-04-25
DE69826034T2 (de) 2005-09-08
DE69826034D1 (de) 2004-10-07
CN1280569A (zh) 2001-01-17
US6329525B1 (en) 2001-12-11
US6380384B1 (en) 2002-04-30
AU1350999A (en) 1999-06-16
CN1118456C (zh) 2003-08-20
EP1048655A4 (de) 2001-04-18
US20020049323A1 (en) 2002-04-25
HK1034074A1 (en) 2001-10-12
AU736232B2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
NO20034595L (no) Kinolin- og kinazolinderivater med azolylgruppe
DE69827785D1 (de) 1,4-substituierte cyclische aminderivate
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
EP1468990A4 (de) Piperazinderivat
NO20034788L (no) Pyrazolo[1,5-A]pyridiner og medisiner inneholdende de samme
ATE232528T1 (de) Pyrimidinylpyrazolderivate
DE69828284D1 (de) Naphthyridinderivate oder salze davon
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
ATE275133T1 (de) 1,2-dihydro-2-oxochinolin-derivate
WO2002094770A3 (en) Aminoalcohol derivatives
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
MX9206930A (es) Nuevos compuestos
GB2334032A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
DK1048651T3 (da) Nitrogenholdige tetracykliske forbindelser
EP1241167A4 (de) 3-ethyl, 3-propyl- oder 3-butyl-chroman und -thiochromanderivate
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties